Direct Life & Pension Services Ltd
At Direct Life & Pension Services Ltd our aim is simply to provide our customers with easy access to competitive low cost life insurance allowing you to compare and save. We have arrangements in place with all the main Insurance providers.
Direct Life & Pension Services Ltd has been established since 1990.
Click here to visit our corporate site
Conditions of Web Site Use
At Direct Life & Pension Services Ltd we take privacy very seriously. We only store information about you that is necessary to fulfil any quotation or application request made by you. Direct Life & Pension Services Ltd handle personal information strictly confidentially but we accept no liability for loss of confidentiality through the use of the Internet or E-mail.
The nature of the technology means that the quotes system cannot be 'guaranteed'. Terms are therefore only deemed to form a 'contract' when a proposal is completed and an acceptance letter has been issued by the insurer.
The Site is the property of Direct Life & Pension Services Ltd. None of the data or content found within the site may be reproduced, republished, distributed, posted, sold, transferred, linked to or modified without the express permission of Direct Life & Pension Services Ltd.
You agree that the information provided by Direct Life & Pension Services Ltd is for your personal use only and may not be used for commercial purposes or distributed commercially without the permission of Direct Life & Pension Services Ltd.
Direct Life & Pension Services Ltd assumes no responsibility and shall not be liable for any damage to, or viruses that may infect your computer equipment on account of your access to, use of, or browsing in the site. In no event will Direct Life & Pension Services Ltd be liable for any injury, loss, claim, damage, or any exemplary, punitive, indirect, incidental or consequential damages of any kind (including but not limited to lost profits or lost savings), whether based in contract, tort, strict liability, or otherwise, which arise out of or is in any way connected with
- Any use of this site or content found herein.
- Any failure or delay (including, but not limited to) the use of or inability to use any component of the site.
- The performance or non-performance by Direct Life & Pension Services Ltd even if such party has been advised of the possibility of damages to such parties or any other party.
- The provision of or failure to provide services.
- Any information, software, products, services and related graphics obtained through the site.
This site and the quotes/services available within the pages are designed for the use of residents of the United Kingdom only.
Complaints that cannot be settled through our own internal complaints procedure may be referred to the Financial Ombudsman Service
03 July 2008 17:55:57
An outbreak of the bug Clostridium Difficile has led to a record number of pensioners in Scotland contracting the virus which could effect UK life insurance for those that have C Diff.
Figures showed that there were 1861 cases of C Diff among the over 65s between January and March of this year - a 14 per cent increase from a similar time period in 2007.
These figures are released following an outbreak at Vale of Leven Hospital in west Dunbartonshire, where nine people were killed and a further 50 were infected with the C Diff bug.
Health Secretary, Nicola Sturgeon, said that she had asked health boards to ensure systems for tackling hospital infections are being followed.
She said: "Scotland has one of the most comprehensive sets of policies and procedures to manage healthcare associated infection (HAI) in Europe.
"However, recent events at the Vale of Leven show how vital it is for boards to ensure that these policies and procedures are applied to a high standard."
Normal fatality rates for people that contract C Diff are at 7 per cent, however at Vale Leven this increased to 30 per cent - when taking into account the further 16 deaths directly linked to the outbreak.
Contracting a superbug may well effect patients life insurance policies.
03 July 2008 17:48:03
A government fertility watchdog has given the go-ahead for stem cell research that will be used to study fatal heart diseases.
Warwick Medical School researchers will use part-human and part-animal embryos for the first time to carry out their study which could eventually have an effect on the cost of life insurance policies for patients with heart disease.
The team plans to create embryos that are 99.9 per cent human DNA and 0.1 per cent pig DNA and stem cells extracted from the embryos will be grown into human heart cells.
Chemicals will be used to destroy the pig DNA before the researchers grow the human heart cells.
Justin St John, heading up the research team, explained what they hope to achieve from the process: "Ultimately they will help us understand where some of the problems associated with these diseases arise, and they could also provide models for the pharmaceutical industry to test new drugs."
Licenses have been granted to two other British teams that are hoping to create hybrid embryos but neither planned to extract animal DNA from the stem cells first.
Conditions such as heart disease can often have an impact on the cost of UK life insurance.
02 July 2008 17:03:39
A baby born with half a heart has just two weeks to live unless a donor can be found, doctors have told his parents.
Born with Hypoplastic Left Heart Syndrome, Theo Davies is currently on a life support machine which can only keep him alive for a short period of time, unless he has a transplant.
Talking about her desperation, Theo's mother Rebecca Giles, said: "People say 'Oh, it must be a nightmare for you'. But it's worse than that. I can't think of a worse situation to be in."
She continued: "Our child will die in two weeks unless we can find a heart donor. But to find another heart for Theo means that another child will die."
Theo has already had to endure five major operations since he was born and survived his heart stopping for an hour last week.
Surgeons in the US are about to undertake the first implantation of a Jarvik heart pump which, it is hoped, could help to solve a shortage of donor hearts.
One of the biggest difficulties facing people with heart problems is securing regular life insurance.
